Q2 2022

Filed Aug 15, 2022 · 10-Q · 46 days after period end · 0001493152-22-022753

Q2 2022 · 10-Q

Revenue

$14.98K

no prior Q2 2021 on file

Net Income

$1.08K

N/M vs Q2 2021

EPS, diluted—

Operating Income$1,077N/M

Operating Cash Flowderived-$22,547N/M

Same quarter

Metric	Q2 2022	Q2 2021	Q2 2020	Q2 2019
Revenue	$14.98K	—	$0.00	$23.00K
Net Income	$1.08K	-$52.74K	-$53.65K	-$4.95K
EPS Diluted	—	$0.00	$0.00	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

NP Life Sciences Health Industry Group Inc. · CIK 1781726 · Engraved from SEC EDGAR